Copyright Reports & Markets. All rights reserved.

Global Cancer Vaccine Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Cancer Vaccine Market Overview

      • 1.1 Product Overview and Scope of Cancer Vaccine
      • 1.2 Cancer Vaccine Segment by Type
        • 1.2.1 Global Cancer Vaccine Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Preventive vaccines
        • 1.2.3 Therapeutic vaccines
      • 1.3 Cancer Vaccine Segment by Application
        • 1.3.1 Cancer Vaccine Consumption Comparison by Application (2014-2025)
        • 1.3.2 Prostate Cancer
        • 1.3.3 Cervical Cancer
        • 1.3.4 Others
      • 1.4 Global Cancer Vaccine Market by Region
        • 1.4.1 Global Cancer Vaccine Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Cancer Vaccine Market Size
        • 1.5.1 Global Cancer Vaccine Revenue (2014-2025)
        • 1.5.2 Global Cancer Vaccine Production (2014-2025)

      2 Global Cancer Vaccine Market Competition by Manufacturers

      • 2.1 Global Cancer Vaccine Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Cancer Vaccine Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Cancer Vaccine Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Cancer Vaccine Production Sites, Area Served, Product Types
      • 2.5 Cancer Vaccine Market Competitive Situation and Trends
        • 2.5.1 Cancer Vaccine Market Concentration Rate
        • 2.5.2 Cancer Vaccine Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Cancer Vaccine Production Market Share by Regions

      • 3.1 Global Cancer Vaccine Production Market Share by Regions
      • 3.2 Global Cancer Vaccine Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Cancer Vaccine Production
        • 3.4.1 North America Cancer Vaccine Production Growth Rate (2014-2019)
        • 3.4.2 North America Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Cancer Vaccine Production
        • 3.5.1 Europe Cancer Vaccine Production Growth Rate (2014-2019)
        • 3.5.2 Europe Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Cancer Vaccine Production (2014-2019)
        • 3.6.1 China Cancer Vaccine Production Growth Rate (2014-2019)
        • 3.6.2 China Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Cancer Vaccine Production (2014-2019)
        • 3.7.1 Japan Cancer Vaccine Production Growth Rate (2014-2019)
        • 3.7.2 Japan Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Cancer Vaccine Consumption by Regions

      • 4.1 Global Cancer Vaccine Consumption by Regions
      • 4.2 North America Cancer Vaccine Consumption (2014-2019)
      • 4.3 Europe Cancer Vaccine Consumption (2014-2019)
      • 4.4 China Cancer Vaccine Consumption (2014-2019)
      • 4.5 Japan Cancer Vaccine Consumption (2014-2019)

      5 Global Cancer Vaccine Production, Revenue, Price Trend by Type

      • 5.1 Global Cancer Vaccine Production Market Share by Type (2014-2019)
      • 5.2 Global Cancer Vaccine Revenue Market Share by Type (2014-2019)
      • 5.3 Global Cancer Vaccine Price by Type (2014-2019)
      • 5.4 Global Cancer Vaccine Production Growth by Type (2014-2019)

      6 Global Cancer Vaccine Market Analysis by Applications

      • 6.1 Global Cancer Vaccine Consumption Market Share by Application (2014-2019)
      • 6.2 Global Cancer Vaccine Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Cancer Vaccine Business

      • 7.1 Dendreon Corporation
        • 7.1.1 Dendreon Corporation Cancer Vaccine Production Sites and Area Served
        • 7.1.2 Cancer Vaccine Product Introduction, Application and Specification
        • 7.1.3 Dendreon Corporation Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 NeoStem Oncology
        • 7.2.1 NeoStem Oncology Cancer Vaccine Production Sites and Area Served
        • 7.2.2 Cancer Vaccine Product Introduction, Application and Specification
        • 7.2.3 NeoStem Oncology Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 ImmunoGen
        • 7.3.1 ImmunoGen Cancer Vaccine Production Sites and Area Served
        • 7.3.2 Cancer Vaccine Product Introduction, Application and Specification
        • 7.3.3 ImmunoGen Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Inovio Pharmaceuticals
        • 7.4.1 Inovio Pharmaceuticals Cancer Vaccine Production Sites and Area Served
        • 7.4.2 Cancer Vaccine Product Introduction, Application and Specification
        • 7.4.3 Inovio Pharmaceuticals Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Novartis
        • 7.5.1 Novartis Cancer Vaccine Production Sites and Area Served
        • 7.5.2 Cancer Vaccine Product Introduction, Application and Specification
        • 7.5.3 Novartis Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served

      8 Cancer Vaccine Manufacturing Cost Analysis

      • 8.1 Cancer Vaccine Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Cancer Vaccine
      • 8.4 Cancer Vaccine Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Cancer Vaccine Distributors List
      • 9.3 Cancer Vaccine Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Cancer Vaccine Market Forecast

      • 11.1 Global Cancer Vaccine Production, Revenue Forecast
        • 11.1.1 Global Cancer Vaccine Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Cancer Vaccine Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Cancer Vaccine Price and Trend Forecast (2019-2025)
      • 11.2 Global Cancer Vaccine Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Cancer Vaccine Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Cancer Vaccine Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Cancer Vaccine Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Cancer Vaccine Production, Revenue Forecast (2019-2025)
      • 11.3 Global Cancer Vaccine Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Cancer Vaccine Consumption Forecast (2019-2025)
        • 11.3.2 Europe Cancer Vaccine Consumption Forecast (2019-2025)
        • 11.3.3 China Cancer Vaccine Consumption Forecast (2019-2025)
        • 11.3.4 Japan Cancer Vaccine Consumption Forecast (2019-2025)
      • 11.4 Global Cancer Vaccine Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Cancer Vaccine Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies or in combination with traditional cancer therapeutics such as chemotherapy and surgery. As cancer is often associated with high mortality rate and are resistant to traditional treatments like chemotherapy and radiation, this has led to the research and development of anti-cancer immunotherapies. The side effects of cancer vaccines may differ from person to person. The most commonly reported are inflation at the site of injection, fever, chills, nausea, blood pressure, and among others.

        The global Cancer Vaccine market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Cancer Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Dendreon Corporation
        NeoStem Oncology
        ImmunoGen
        Inovio Pharmaceuticals
        Novartis
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Preventive vaccines
        Therapeutic vaccines

        Segment by Application
        Prostate Cancer
        Cervical Cancer
        Others

        Buy now